The protease medicines company
Learn more
Catalyst Biosciences Announces Plan to Distribute Cash to Stockholders
Catalyst Biosciences Sells Complement Portfolio for $60 Million
Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results
More news
